Ming-Hong Xie

Ming-Hong Xie has extensive work experience in the pharmaceutical industry. They started their career at Genentech in 1994 as an SRA and worked there until 2011. Following that, they joined OncoMed Pharmaceuticals where they held roles as a senior scientist from 2011 to 2016 and as an associate director from 2017 to 2018. Currently, Ming-Hong Xie is working as a Principal Scientist at Nkarta Therapeutics, Inc, a position they have held since February 2019.

Ming-Hong Xie holds a Doctor of Medicine (MD) degree from Nanjing Medical University, where they specialized in the field of Medicine.